Objective To evaluate cervical cancer screening with primary human papillomavirus (HPV) testing in Mozambique, a country with one of the highest burdens of cervical cancer globally. Methods Women aged 30–49 years were prospectively enrolled and offered primary HPV testing using either self- collected o...
Background: Cost is an important determinant of health program implementation. In this study, we conducted a comprehensive evaluation of the implementation strategy of Mozambique’s school-based HPV vaccine demonstration project. We sought to estimate the total costs for the program, cost per fully immu...
Sub-Saharan Africa concentrates the largest burden of cervical cancer worldwide. The introduction of the HPV vaccination in this region is urgent and strategic to meet global health targets. This was a cross-sectional study conducted in Mozambique prior to the first round of the HPV vaccine demonstration...
In May 2014, Mozambique launched a vaccination demonstration program
against cervical cancer focusing on 10 year old girls according to WHO recommendations. Although
the acceptability study revealed a high level of theoretical acceptability of the vaccination
in the Manhiça district, it did not guarante...
Objectives: Human papillomavirus (HPV) is a well-known cause of cervical cancer, the second most frequent cancer in female African populations. This study aimed at determining the prevalence of HPV infections and the genotype distribution in young adults aged 18-24, in Maputo city, Mozambique, and to ass...
Em Moçambique, o cancro do colo do útero corresponde a cerca de um terço dos casos de cancro na mulher, reflectindo a elevada prevalência de infecção peloVírus do Papiloma Humano (Human papillomavirus – HPV). Actualmente, todas as províncias são abrangidas por um programa de rastreio por inspe...
